TY - JOUR
T1 - Rethinking heart failure care and health technologies from early COVID-19 experiences - A narrative review
AU - Satici, Sakine
AU - Iyngkaran, Pupalan
AU - Andrew, Sharon
AU - Patil, Arun
AU - Bidargaddi, Niranjan
AU - Battersby, Malcolm
AU - de Courten, Maximilian
N1 - Publisher Copyright:
© 2021 The Authors. Published by IMR Press.
PY - 2021/3
Y1 - 2021/3
N2 - Heart Failure (HF), a common chronic disease, requires multidisciplinary care to optimise outcomes. The COVID-19 pandemic, its impact on people's movement and access to health services, introduced severe challenges to chronic disease management. The era that will evolve after this pandemic is likely to provide uncertainty and service model disruptions. HF treatment is based on guidelines derived from randomised clinical trial evidence. Translational shortfalls from trials into practice have been overcome with post-trial service improvement studies like OPTIMIZE-HF where a team using a process of care can translate evidence to the general population. However, gaps remain for vulnerable populations e.g. those with more severe HF, with multiple comorbid conditions, and certain demographic groups and/or residents in remote locations. Health technology has come with great promise, to fill some of these gaps. The COVID-19 pandemic provides an opportunity to observe, from Australian healthcare lens, HF management outside the traditional model of care. This narrative review describes relatively recent events with health technology as a solution to improve on service gaps.
AB - Heart Failure (HF), a common chronic disease, requires multidisciplinary care to optimise outcomes. The COVID-19 pandemic, its impact on people's movement and access to health services, introduced severe challenges to chronic disease management. The era that will evolve after this pandemic is likely to provide uncertainty and service model disruptions. HF treatment is based on guidelines derived from randomised clinical trial evidence. Translational shortfalls from trials into practice have been overcome with post-trial service improvement studies like OPTIMIZE-HF where a team using a process of care can translate evidence to the general population. However, gaps remain for vulnerable populations e.g. those with more severe HF, with multiple comorbid conditions, and certain demographic groups and/or residents in remote locations. Health technology has come with great promise, to fill some of these gaps. The COVID-19 pandemic provides an opportunity to observe, from Australian healthcare lens, HF management outside the traditional model of care. This narrative review describes relatively recent events with health technology as a solution to improve on service gaps.
KW - Chronic disease management
KW - Congestive heart failure
KW - Health hubs
KW - Health technology
KW - Heart failure
KW - Self-management
UR - http://www.scopus.com/inward/record.url?scp=85103744159&partnerID=8YFLogxK
U2 - 10.31083/J.RCM.2021.01.272
DO - 10.31083/J.RCM.2021.01.272
M3 - Review article
C2 - 33792252
AN - SCOPUS:85103744159
SN - 1530-6550
VL - 22
SP - 105
EP - 114
JO - Reviews in Cardiovascular Medicine
JF - Reviews in Cardiovascular Medicine
IS - 1
ER -